Investment Analysts’ Recent Ratings Changes for Anthem (ANTM)

A number of research firms have changed their ratings and price targets for Anthem (NYSE: ANTM):

  • 5/4/2022 – Anthem had its price target raised by analysts at Mizuho from $510.00 to $545.00.
  • 4/25/2022 – Anthem had its price target raised by analysts at BMO Capital Markets from $540.00 to $625.00. They now have an “outperform” rating on the stock.
  • 4/22/2022 – Anthem was given a new $586.00 price target on by analysts at Wells Fargo & Company. They now have an “overweight” rating on the stock.
  • 4/22/2022 – Anthem had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $453.00 to $574.00. They now have a “buy” rating on the stock.
  • 4/21/2022 – Anthem had its price target raised by analysts at Morgan Stanley from $518.00 to $607.00. They now have an “overweight” rating on the stock.
  • 4/21/2022 – Anthem had its price target raised by analysts at Credit Suisse Group AG from $518.00 to $584.00. They now have an “outperform” rating on the stock.
  • 4/21/2022 – Anthem had its price target raised by analysts at SVB Leerink LLC from $483.00 to $555.00. They now have a “market perform” rating on the stock.
  • 4/21/2022 – Anthem had its price target raised by analysts at The Goldman Sachs Group, Inc. from $527.00 to $605.00. They now have a “buy” rating on the stock.
  • 4/21/2022 – Anthem had its price target raised by analysts at Cowen Inc. from $472.00 to $642.00.
  • 4/21/2022 – Anthem had its price target raised by analysts at Jefferies Financial Group Inc. from $575.00 to $625.00.
  • 4/21/2022 – Anthem had its price target raised by analysts at Truist Financial Co. from $590.00 to $610.00.
  • 4/21/2022 – Anthem had its price target raised by analysts at Cowen Inc from $472.00 to $642.00.
  • 4/7/2022 – Anthem had its price target raised by analysts at Truist Financial Co. from $540.00 to $590.00.
  • 3/31/2022 – Anthem is now covered by analysts at StockNews.com. They set a “strong-buy” rating on the stock.
  • 3/29/2022 – Anthem had its “buy” rating reaffirmed by analysts at Jefferies Financial Group Inc.. They now have a $559.00 price target on the stock.
  • 3/29/2022 – Anthem had its price target raised by analysts at UBS Group AG from $477.00 to $541.00. They now have a “buy” rating on the stock.
  • 3/15/2022 – Anthem had its price target raised by analysts at SVB Leerink LLC from $465.00 to $483.00. They now have a “market perform” rating on the stock.

Shares of NYSE ANTM traded up $7.18 during trading on Wednesday, reaching $496.50. The company had a trading volume of 20,470 shares, compared to its average volume of 1,202,936. Anthem, Inc. has a 52 week low of $355.43 and a 52 week high of $533.68. The stock has a market cap of $119.70 billion, a PE ratio of 19.55, a PEG ratio of 1.42 and a beta of 0.97. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.36 and a current ratio of 1.36. The business’s 50 day moving average price is $492.71 and its 200-day moving average price is $457.97.

Anthem (NYSE:ANTMGet Rating) last released its quarterly earnings results on Wednesday, April 20th. The company reported $8.25 earnings per share for the quarter, beating the consensus estimate of $7.81 by $0.44. Anthem had a net margin of 4.33% and a return on equity of 18.71%. The company had revenue of $38.10 billion during the quarter, compared to analysts’ expectations of $37.28 billion. During the same quarter in the prior year, the company earned $7.01 earnings per share. The business’s quarterly revenue was up 17.6% compared to the same quarter last year. Equities analysts anticipate that Anthem, Inc. will post 28.55 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 24th. Investors of record on Friday, June 10th will be given a dividend of $1.28 per share. This represents a $5.12 dividend on an annualized basis and a yield of 1.03%. This is a positive change from Anthem’s previous quarterly dividend of $1.13. The ex-dividend date of this dividend is Thursday, June 9th. Anthem’s dividend payout ratio (DPR) is currently 20.16%.

In other Anthem news, EVP Peter D. Haytaian sold 17,703 shares of the firm’s stock in a transaction that occurred on Thursday, March 10th. The shares were sold at an average price of $460.71, for a total transaction of $8,155,949.13. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Ronald W. Penczek sold 2,423 shares of Anthem stock in a transaction on Thursday, March 3rd. The shares were sold at an average price of $463.68, for a total transaction of $1,123,496.64. The disclosure for this sale can be found here. 0.27% of the stock is currently owned by company insiders.

A number of institutional investors and hedge funds have recently bought and sold shares of ANTM. State Street Corp raised its holdings in shares of Anthem by 1.5% during the 4th quarter. State Street Corp now owns 10,732,795 shares of the company’s stock worth $4,975,080,000 after acquiring an additional 162,857 shares in the last quarter. Capital International Investors raised its stake in shares of Anthem by 8.4% in the fourth quarter. Capital International Investors now owns 5,638,163 shares of the company’s stock worth $2,613,667,000 after purchasing an additional 437,816 shares during the last quarter. Baillie Gifford & Co. grew its holdings in Anthem by 14.7% in the fourth quarter. Baillie Gifford & Co. now owns 4,582,312 shares of the company’s stock valued at $2,124,085,000 after purchasing an additional 587,649 shares during the period. Geode Capital Management LLC lifted its position in shares of Anthem by 1.3% in the fourth quarter. Geode Capital Management LLC now owns 4,174,578 shares of the company’s stock valued at $1,929,914,000 after acquiring an additional 51,641 shares in the last quarter. Finally, Sanders Capital LLC lifted its position in Anthem by 1.6% during the fourth quarter. Sanders Capital LLC now owns 4,042,601 shares of the company’s stock worth $2,074,078,000 after buying an additional 65,439 shares in the last quarter. Institutional investors and hedge funds own 84.28% of the company’s stock.

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets.

Featured Articles

Receive News & Ratings for Anthem Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem Inc and related companies with MarketBeat.com's FREE daily email newsletter.